Advanced-stage evidence supports perioperative investigation but cannot establish benefit in resectable disease, and progress requires accurate variant-level testing and randomized trials defining pathological response, surgical feasibility, toxicity, central nervous system (CNS) control, DFS, and OS.
Zhuo-Ran Li, Yi-Chao Han, Wen-Zhao Zhong et al.· Translational Lung Cancer Re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.